These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 31006121)
21. What is the factor that improves adherence to allergen-specific immunotherapy? A secretary! Lombardi C Ann Allergy Asthma Immunol; 2015 Jun; 114(6):530-1. PubMed ID: 25863450 [No Abstract] [Full Text] [Related]
23. Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin. Ngan J; Kind LS J Immunol; 1978 Mar; 120(3):861-5. PubMed ID: 305448 [TBL] [Abstract][Full Text] [Related]
24. Treatment of autoimmune diseases by oral tolerance to autoantigens. Weiner HL; Miller A; Khoury SJ; Zhang ZJ; al-Sabbagh A; Brod SA; Lider O; Higgins P; Sobel R; Matsui M Adv Exp Med Biol; 1995; 371B():1217-23. PubMed ID: 7502787 [No Abstract] [Full Text] [Related]
25. Allergen extracts for immunotherapy: to mix or not to mix? Nony E; Martelet A; Jain K; Moingeon P Expert Rev Clin Pharmacol; 2016; 9(3):401-8. PubMed ID: 26652799 [TBL] [Abstract][Full Text] [Related]
26. Oral administration of the AYA strain of Lactobacillus plantarum modulates expression of immunity-related genes in the murine Peyer's patch: a DNA microarray analysis. Kikuchi Y; Toyoda T; Ishijima T; Abe K; Nakai Y; Fukudome S Biosci Biotechnol Biochem; 2014; 78(11):1935-8. PubMed ID: 25117913 [TBL] [Abstract][Full Text] [Related]
27. No impairment of local intestinal immune response to keyhole limpet haemocyanin in the absence of Peyer's patches. Hamilton SR; Keren DF; Yardley JH; Brown G Immunology; 1981 Mar; 42(3):431-5. PubMed ID: 7203530 [TBL] [Abstract][Full Text] [Related]
35. Immunotherapy with allergens. Creticos PS; Norman PS JAMA; 1987 Nov; 258(20):2874-80. PubMed ID: 3312669 [No Abstract] [Full Text] [Related]
36. Allergen immunotherapy, routes of administration and cytokine networks: an update. Cuppari C; Leonardi S; Manti S; Filippelli M; Alterio T; Spicuzza L; Rigoli L; Arrigo T; Lougaris V; Salpietro C Immunotherapy; 2014; 6(6):775-86. PubMed ID: 25186606 [TBL] [Abstract][Full Text] [Related]
37. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines. Mascarell L; Van Overtvelt L; Moingeon P Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145 [TBL] [Abstract][Full Text] [Related]
38. One more step towards a deeper understanding of the mechanisms of allergen immunotherapy. Incorvaia C EBioMedicine; 2018 Nov; 37():34-35. PubMed ID: 30314896 [No Abstract] [Full Text] [Related]
39. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing. Yanagawa Y; Masubuchi Y; Chiba K Immunology; 1998 Dec; 95(4):591-4. PubMed ID: 9893050 [TBL] [Abstract][Full Text] [Related]
40. Dog allergen immunotherapy and allergy to furry animals. Liccardi G; Salzillo A; Calzetta L; Ora J; Rogliani P Ann Allergy Asthma Immunol; 2016 Jun; 116(6):590. PubMed ID: 27264567 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]